Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-064905

Director sold 5,000 shares at $18.00 ($90,000)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mirza Mansoor Raza · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-18 Exercise or conversion : show line 1 in the form +5,000 $5.43 $27,150 5,000 D
2020-12-18 Sale : show line 2 in the form −5,000 $18.00 $90,000 0 D
Open-market sales · 5,000 sh · avg $18.00 · $90,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-18 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −5,000 $5.43 2029-06-05 5,000 0 D
Loading xslF345X03/doc4.xml…